Image Source: Facebook
Jeena Sikho Lifecare Ltd has received regulatory approval to initiate clinical trials of its patent diabetes tablets, a landmark in the company's journey to find a solution for Ayurveda-based treatment of chronic lifestyle diseases. The clearance paves the way for the company to scientifically validate the safety and efficacy of its herbal formulations aimed at managing type 2 diabetes.
Coming trials will check the company's plant-based diabetes tablets, which are a part of its larger group of Ayurvedic healthcare products. Jeena Sikho currently sells a range of diabetes care supplements—JS-DIAB Capsules, Madhumeh Nashak Syrup, and Dr. Diab Tablets—that blend traditional herbs like Gudmar, Neem, and Karela to regulate blood sugar.
This clearance of the clinical trial is bound to lend further credibility to Jeena Sikho's product line and open doors to conventional medical acceptance and global business expansion. This also suggests a growing trend towards the integration of evidence-based Ayurveda into modern healthcare models.
Sources: Jeena Sikho Diabetes Care Product Line, Amazon, Reuters
Advertisement
Advertisement